Marshall Wace’s AbbVie ABBV Stock Holding History

Marshall Wace’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-188,300	Closed	-$29.2M	–	2387
2023 Q4	$29.2M	Buy	+188,300	New	+$27.5M	0.05%	369
2023 Q3	–	Sell	-72,700	Closed	-$9.79M	–	2129
2023 Q2	$9.79M	Buy	72,700 +66,500	+1,073%	+$9.75M	0.02%	736
2023 Q1	$988K	Buy	+6,200	New	+$948K	﹤0.01%	1816
2022 Q4	–	Sell	-7,600	Closed	-$1.02M	–	2873
2022 Q3	$1.02M	Buy	+7,600	New	+$1.09M	﹤0.01%	2395
2021 Q4	–	Sell	-300	Closed	-$32K	–	3808
2021 Q3	$32K	Buy	+300	New	+$34.3K	﹤0.01%	2948
2021 Q2	–	Sell	-15,900	Closed	-$1.72M	–	2594
2021 Q1	$1.72M	Buy	+15,900	New	+$1.7M	0.01%	1396

Other funds holding ABBV

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Marshall Wace's ABBV Position: Q2 2026 in Review

Marshall Wace increased its AbbVie (ABBV) stake by 281,758% in Q2 2026, buying an estimated $643M and bringing the position to 2,990,512 shares worth $753M. The position accounts for 0.59% of the portfolio, ranked #17.

Marshall Wace first reported a position in ABBV in Q3 2014 and has held it in 39 quarters since. 4,216 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

Marshall Wace held 2,990,512 shares of AbbVie worth $753M as of Q2 2026.
Marshall Wace bought 2,989,451 AbbVie shares in Q2 2026, an estimated $643M.
AbbVie made up 0.59% of Marshall Wace's portfolio in Q2 2026, its #17 holding.
Marshall Wace first reported a position in AbbVie in Q3 2014 and has held it in 39 quarters since.
4,216 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Marshall Wace's 13F filing for Q2 2026, filed 13 Aug 2026.